30237-8900Level 3
PROVENGE (sipuleucel-T)
**Product type:** Cellular Therapy
**Active ingredient:** SIPULEUCEL-T
**Strength:** 50000000 1/1
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** Dendreon Pharmaceuticals LLC
**Marketing category:** BLA (BLA125197)
**Pharmacologic class:** Autologous Cellular Immunotherapy [EPC], Cell-mediated Immunity [PE], Cells, Cultured, Autologous [EXT], Leukocytes, Mononuclear [CS]
GET
/api/v1/systems/ndc_fda/nodes/30237-8900Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.